Kudo, M. (2021). A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers.
Chicago Style (17th ed.) CitationKudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.
MLA (8th ed.) CitationKudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.
Warning: These citations may not always be 100% accurate.